(1-Benzylazetidin-3-yl)methanamine dihydrochloride, 95+%, 250mg

ETHYL 2-(TERT-BUTOXYCARBONYL(3-CYANOPROPYL)AMINO)ACETATE, 95.0%, 250mg

1-Bromo-2-iodobenzene (stabilized with Copper chip)>98.0%(GC)5g

�-Nicotinamide Adenine Dinucleotide Phosphate Sodium Salt Hydrate, oxidized form [for Biochemical Research], 90.0%, 1g

Spectra/Por® 1, Dialysemembranen, MWCO 6000 - 8000, Breite 100 mm, 1 Stück

(R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 25g

Sodium Trimethylacetate xHydrate, 97%, 25g

Ethyl 3-bromo-4-chlorobenzoate, 95.0%, 25g

(3,4-Dichlorophenyl)(phenyl)methanamine hydrochloride, 98%, 100mg

Ethyl 6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 95+%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 1g

(S)-(-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol[e.e.determination reagent], 99.0%, 250mg

Ethyl 2-(3-oxo-3,4-dihydro-2H-1,4-benzothiazin-2-yl) acetate, 1g